{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:32:06Z","timestamp":1761863526824,"version":"build-2065373602"},"reference-count":33,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,2,24]],"date-time":"2013-02-24T00:00:00Z","timestamp":1361664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      Visceral adipose tissue (\n                      <jats:styled-content style=\"fixed-case\">VAT<\/jats:styled-content>\n                      ) and liver fat (\n                      <jats:styled-content style=\"fixed-case\">LF<\/jats:styled-content>\n                      ) are strongly associated with type 2 diabetes. It is not known, however, how diabetes treatment and\/or risk factor management modulates the association between\n                      <jats:styled-content style=\"fixed-case\">VAT<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">LF<\/jats:styled-content>\n                      and diabetes. The aim was to determine the level of\n                      <jats:styled-content style=\"fixed-case\">VAT<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">LF<\/jats:styled-content>\n                      in patients with type 2 diabetes according to their treatment status and achievement of the American Diabetes Association's (\n                      <jats:styled-content style=\"fixed-case\">ADA<\/jats:styled-content>\n                      ) diabetes management goals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a cross\u2010sectional analysis of the baseline data of the International Study of the Prediction of Intra\u2010Abdominal Adiposity and its Relationship with Cardiometabolic risk\/Intra\u2010Abdominal Adiposity (\n                      <jats:styled-content style=\"fixed-case\">INSPIRE ME IAA<\/jats:styled-content>\n                      ), a 3\u2010year prospective cardiometabolic imaging study conducted in 29 countries. Patients (n\u2009=\u20093991) were divided into four groups: (i) those without type 2 diabetes (\n                      <jats:styled-content style=\"fixed-case\">noT2D<\/jats:styled-content>\n                      n\u2009=\u20091003 men, n\u2009=\u20091027 women); (ii) those with type 2 diabetes but not treated with diabetes medications (\n                      <jats:styled-content style=\"fixed-case\">T2Dnomeds<\/jats:styled-content>\n                      n\u2009=\u2009248 men, n\u2009=\u2009198 women); (iii) those with type 2 diabetes and treated with diabetes medications but not yet using insulin (\n                      <jats:styled-content style=\"fixed-case\">T2Dmeds<\/jats:styled-content>\n                      \u2010ins n\u2009=\u2009591 men, n\u2009=\u2009484 women) and (iv) those with type 2 diabetes and treated with insulin (\n                      <jats:styled-content style=\"fixed-case\">T2Dmeds<\/jats:styled-content>\n                      +ins n\u2009=\u2009233 men, n\u2009=\u2009207 women). Abdominal and liver adiposity were measured by computed tomography.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fewer patients with high\n                      <jats:styled-content style=\"fixed-case\">VAT<\/jats:styled-content>\n                      or\n                      <jats:styled-content style=\"fixed-case\">LF<\/jats:styled-content>\n                      achieved the\n                      <jats:styled-content style=\"fixed-case\">ADA<\/jats:styled-content>\n                      's goals for high\u2010density lipoprotein cholesterol (\n                      <jats:styled-content style=\"fixed-case\">HDL<\/jats:styled-content>\n                      \u2010C) or triglycerides compared to patients with low\n                      <jats:styled-content style=\"fixed-case\">VAT<\/jats:styled-content>\n                      or\n                      <jats:styled-content style=\"fixed-case\">LF<\/jats:styled-content>\n                      . Visceral adiposity (p\u2009=\u20090.02 men, p\u2009=\u20090.003 women) and\n                      <jats:styled-content style=\"fixed-case\">LF<\/jats:styled-content>\n                      (p\u2009=\u20090.0002 men, p\u2009=\u20090.0004 women) increased among patients who met fewer of the\n                      <jats:styled-content style=\"fixed-case\">ADA<\/jats:styled-content>\n                      treatment criteria, regardless of type 2 diabetes treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Residual cardiometabolic risk exists among patients with type 2 diabetes characterized by elevated\n                      <jats:styled-content style=\"fixed-case\">VAT<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">LF<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.12075","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T08:26:14Z","timestamp":1359361574000},"page":"629-641","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and\/or other diabetic medications: results from\n                    <scp>INSPIRE ME IAA<\/scp>"],"prefix":"10.1111","volume":"15","author":[{"given":"J.","family":"Smith","sequence":"first","affiliation":[{"name":"Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec  Qu\u00e9bec QC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010A.","family":"Nazare","sequence":"additional","affiliation":[{"name":"Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec  Qu\u00e9bec QC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.\u2010L.","family":"Borel","sequence":"additional","affiliation":[{"name":"HP2 Laboratory INSERM U1042, h\u00f4pital universitaire de Grenoble, P\u00f4le DIGI\u2010DUNE d\u00e9partement d'endocrinologie, diab\u00e9tologie, maladie de la nutrition  Grenoble France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Aschner","sequence":"additional","affiliation":[{"name":"Pontificia Universidad Javeriana, Hospital Universitario San Ignacio  Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Barter","sequence":"additional","affiliation":[{"name":"Heart Research Institute, Camperdown  Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Van Gaal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolism &amp; Clinical Nutrition Antwerp University Hospital  Edegem Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Matsuzawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Sumitomo Hospital  Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kadowaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Metabolic Diseases, Graduate School of Medicine The University of Tokyo  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ross","sequence":"additional","affiliation":[{"name":"School of Kinesiology and Health Studies Queen's University  Kingston ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brulle\u2010Wohlhueter","sequence":"additional","affiliation":[{"name":"Sanofi  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Alm\u00e9ras","sequence":"additional","affiliation":[{"name":"Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec  Qu\u00e9bec QC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Haffner","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine  Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Balkau","sequence":"additional","affiliation":[{"name":"INSERM, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of diabetes, obesity and chronic kidney disease over the lifecourse and determinants of early nutrition University Paris Sud 11  Villejuif France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010P.","family":"Despr\u00e9s","sequence":"additional","affiliation":[{"name":"Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec  Qu\u00e9bec QC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,2,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.16.14.1853e"},{"volume-title":"Diabetes Data & Trends","year":"2011","author":"CDC","key":"e_1_2_7_3_1"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm124"},{"issue":"1","key":"e_1_2_7_5_1","first-page":"S11","article-title":"Standards of medical care in diabetes. 2012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"e_1_2_7_6_1","first-page":"S1","article-title":"2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","author":"Canadian Diabetes Association","year":"2008","journal-title":"Can J Diabetes"},{"volume-title":"Federation","year":"2004","author":"WHO\/IDF","key":"e_1_2_7_7_1"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2550"},{"key":"e_1_2_7_9_1","first-page":"187","article-title":"Techniques for the measurement of visceral fat: a practical guide","volume":"17","author":"Kooy K","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_7_10_1","first-page":"E736","article-title":"Determination of total adipose tissue and body fat in women by computed tomography, 40\u2009K, and tritium","volume":"250","author":"Sjostrom L","year":"1986","journal-title":"Am J Physiol"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/54.3.471"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1079\/BJN19890104"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1602-5"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00986.2005"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2011.06.024"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-10-56"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.213"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22845"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1464-y"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05488"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03360.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.11.015"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0003319711410226"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0157"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-6-200109180-00014"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.016337"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-12-86"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2011.35.3.264"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-31"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2010.00311.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2010.08.009"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-011-0220-3"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/11208090-000000000-00000"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.12075","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.12075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:26:11Z","timestamp":1761863171000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.12075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,24]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1111\/dom.12075"],"URL":"https:\/\/doi.org\/10.1111\/dom.12075","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2013,2,24]]}}}